• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺癌细胞中致癌蛋白激酶 Pim-1 稳定前列腺特异性肿瘤抑制因子 NKX3.1。

Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.

机构信息

Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD, USA.

出版信息

J Cell Biochem. 2013 May;114(5):1050-7. doi: 10.1002/jcb.24444.

DOI:10.1002/jcb.24444
PMID:23129228
Abstract

Loss of NKX3.1 is an early and consistent event in prostate cancer and is associated with increased proliferation of prostate epithelial cells and poor prognosis. NKX3.1 stability is regulated post-translationally through phosphorylation at multiple sites by several protein kinases. Here, we report the paradoxical stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells. Pharmacologic Pim-1 inhibition using the small molecule inhibitor CX-6258 decreased steady state levels and half-life of NKX3.1 protein but mRNA was not affected. This effect was reversed by inhibition of the 26S-proteasome, demonstrating that Pim-1 protects NKX3.1 from proteasome-mediated degradation. Mass spectrometric analyses revealed Thr89, Ser185, Ser186, Ser195, and Ser196 as Pim-1 phospho-acceptor sites on NKX3.1. Through mutational analysis, we determined that NKX3.1 phosphorylation at Ser185, Ser186, and within the N-terminal PEST domain is essential for Pim-1-mediated stabilization. Further, we also identified Lys182 as a critical residue for NKX3.1 stabilization by Pim-1. Pim-1-mediated NKX3.1 stabilization may be important in maintaining normal cellular homeostasis in normal prostate epithelial cells, and may maintain basal NKX3.1 protein levels in prostate cancer cells.

摘要

NKX3.1 的缺失是前列腺癌早期且一致的事件,并与前列腺上皮细胞增殖增加和预后不良相关。NKX3.1 的稳定性通过多个蛋白激酶在多个位点的磷酸化进行翻译后调节。在这里,我们报告了致癌蛋白激酶 Pim-1 对前列腺特异性肿瘤抑制因子 NKX3.1 的反常稳定作用。使用小分子抑制剂 CX-6258 进行药理学 Pim-1 抑制会降低 NKX3.1 蛋白的稳定状态水平和半衰期,但对 mRNA 没有影响。这种作用被 26S 蛋白酶体的抑制所逆转,表明 Pim-1 保护 NKX3.1 免受蛋白酶体介导的降解。质谱分析显示 Thr89、Ser185、Ser186、Ser195 和 Ser196 是 NKX3.1 上 Pim-1 的磷酸化接受位点。通过突变分析,我们确定 NKX3.1 在 Ser185、Ser186 和 N 端 PEST 结构域中的磷酸化对于 Pim-1 介导的稳定是必需的。此外,我们还确定了 Lys182 是 Pim-1 稳定 NKX3.1 的关键残基。Pim-1 介导的 NKX3.1 稳定可能对维持正常前列腺上皮细胞的正常细胞内稳态很重要,并可能维持前列腺癌细胞中基础 NKX3.1 蛋白水平。

相似文献

1
Stabilization of the prostate-specific tumor suppressor NKX3.1 by the oncogenic protein kinase Pim-1 in prostate cancer cells.前列腺癌细胞中致癌蛋白激酶 Pim-1 稳定前列腺特异性肿瘤抑制因子 NKX3.1。
J Cell Biochem. 2013 May;114(5):1050-7. doi: 10.1002/jcb.24444.
2
Regulating NKX3.1 stability and function: Post-translational modifications and structural determinants.调控NKX3.1的稳定性和功能:翻译后修饰与结构决定因素
Prostate. 2016 May;76(6):523-33. doi: 10.1002/pros.23144. Epub 2016 Feb 4.
3
The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.肿瘤抑制因子NKX3.1是DYRK1B激酶的降解靶点。
Mol Cancer Res. 2015 May;13(5):913-22. doi: 10.1158/1541-7786.MCR-14-0680. Epub 2015 Mar 16.
4
Proline-mediated proteasomal degradation of the prostate-specific tumor suppressor NKX3.1.脯氨酸介导的前列腺特异性肿瘤抑制因子 NKX3.1 的蛋白酶体降解。
J Biol Chem. 2012 Oct 19;287(43):36331-40. doi: 10.1074/jbc.M112.352823. Epub 2012 Aug 21.
5
Loss of PTEN Accelerates NKX3.1 Degradation to Promote Prostate Cancer Progression.PTEN 缺失加速 NKX3.1 降解促进前列腺癌进展。
Cancer Res. 2019 Aug 15;79(16):4124-4134. doi: 10.1158/0008-5472.CAN-18-4110. Epub 2019 Jun 18.
6
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.双重抑制 RNA 聚合酶 I 转录和 PIM 激酶作为治疗晚期前列腺癌的新治疗方法。
Clin Cancer Res. 2016 Nov 15;22(22):5539-5552. doi: 10.1158/1078-0432.CCR-16-0124. Epub 2016 Aug 2.
7
Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts.Pim激酶促进前列腺癌异种移植瘤的迁移和转移生长。
PLoS One. 2015 Jun 15;10(6):e0130340. doi: 10.1371/journal.pone.0130340. eCollection 2015.
8
NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.NKX3.1在前列腺肿瘤细胞中受蛋白激酶CK2调控。
Mol Cell Biol. 2006 Apr;26(8):3008-17. doi: 10.1128/MCB.26.8.3008-3017.2006.
9
PIM kinase inhibitors downregulate STAT3(Tyr705) phosphorylation.PIM 激酶抑制剂下调 STAT3(Tyr705)磷酸化。
Mol Cancer Ther. 2010 Sep;9(9):2478-87. doi: 10.1158/1535-7163.MCT-10-0321. Epub 2010 Jul 28.
10
Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells.Nkx3.1和p27(KIP1)在人雄激素非依赖性前列腺癌细胞的增殖抑制和凋亡诱导中协同作用。
Cancer Invest. 2009 May;27(4):369-75. doi: 10.1080/07357900802232749.

引用本文的文献

1
Targeting Pim kinases in hematological cancers: molecular and clinical review.靶向血液系统恶性肿瘤的 Pim 激酶:分子与临床综述。
Mol Cancer. 2023 Jan 25;22(1):18. doi: 10.1186/s12943-023-01721-1.
2
PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest.PIM1 通过抑制重编程诱导的铁死亡和细胞周期阻滞促进肝向分化。
Nat Commun. 2022 Sep 6;13(1):5237. doi: 10.1038/s41467-022-32976-9.
3
Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.
雄激素剥夺治疗抵抗性前列腺癌和去势抵抗性神经内分泌前列腺癌模型中 NKX3.1 和 AURKA 轴的相互调控异常。
J Biomed Sci. 2021 Oct 8;28(1):68. doi: 10.1186/s12929-021-00765-z.
4
LIMK2-NKX3.1 Engagement Promotes Castration-Resistant Prostate Cancer.LIMK2与NKX3.1相互作用促进去势抵抗性前列腺癌。
Cancers (Basel). 2021 May 12;13(10):2324. doi: 10.3390/cancers13102324.
5
The Role of Nkx3.1 in Cancers and Stemness.Nkx3.1在癌症和干性中的作用。
Int J Stem Cells. 2021 May 30;14(2):168-179. doi: 10.15283/ijsc20121.
6
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.PIM 激酶抑制:前列腺癌的联合靶向治疗方法。
Signal Transduct Target Ther. 2020 Jan 31;5(1):7. doi: 10.1038/s41392-020-0109-y.
7
Zinc Oxide nanoparticles induce oxidative and proteotoxic stress in ovarian cancer cells and trigger apoptosis Independent of p53-mutation status.氧化锌纳米颗粒在卵巢癌细胞中诱导氧化应激和蛋白毒性应激,并引发凋亡,与p53突变状态无关。
Appl Surf Sci. 2019 Sep;487:807-818. doi: 10.1016/j.apsusc.2019.05.099.
8
USP15-dependent lysosomal pathway controls p53-R175H turnover in ovarian cancer cells.USP15 依赖性溶酶体途径控制卵巢癌细胞中 p53-R175H 的降解。
Nat Commun. 2018 Mar 28;9(1):1270. doi: 10.1038/s41467-018-03599-w.
9
MicroRNA-124-3p regulates cell proliferation, invasion, apoptosis, and bioenergetics by targeting PIM1 in astrocytoma.微小RNA-124-3p通过靶向星形细胞瘤中的PIM1来调节细胞增殖、侵袭、凋亡和生物能量学。
Cancer Sci. 2016 Jul;107(7):899-907. doi: 10.1111/cas.12946. Epub 2016 Jun 21.
10
Protein kinase A regulates MYC protein through transcriptional and post-translational mechanisms in a catalytic subunit isoform-specific manner.蛋白激酶 A 通过转录和翻译后机制以催化亚基同工型特异性的方式调节 MYC 蛋白。
J Biol Chem. 2013 May 17;288(20):14158-14169. doi: 10.1074/jbc.M112.432377. Epub 2013 Mar 15.